5-(Carboethoxymethylidene)hydantoin-13C,15N2 is an intermediate formed in the synthesis of Orotic Acid-13C,15N2 Monohydrate, a labeled orotic acid, used in the preparation of therapeutic agents for chronic obstructive pulmonary disease (COPD) treatment. Molecular Formula: C613CH815N2O4 Solubility: DMSO, hot ethanol Molecular Weight: 187.13 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molekulargewicht:
187.13
Formulierung:
Supplied as a Colorless crystals
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten